5 studies on SLU-PP-332 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This pilot study provides compelling evidence that Estrogen-Related Receptors (ERRs) represent a highly promising and previously under-explored therapeutic target for combating sarcopenia and disuse-induced muscle atr…
This study provides compelling evidence that a synthetic ERR agonist can effectively mitigate multiple symptoms of metabolic syndrome in a preclinical model, underscoring the significant therapeutic potential of targe…
This research highlights the therapeutic potential of targeting ERR pathways to combat heart failure by directly addressing its underlying metabolic dysfunction. By enhancing the heart's ability to generate energy and…